12th Vaccines Research & Development: All Things Considered Conference
Conference - Boston, MA, United States
GTC is proud to present its 12th Vaccines Research & Development: All Things Considered Conference, to be held in Boston, MA on July 9-11, 2014. This conference continues a tradition of presenting valuable updates and exposure to all aspects of vaccine development, including research, product design considerations / specifications, manufacturing, regulations, investment, and policy, in a comfortable, interactive and friendly setting. It brings together the leaders in vaccinology from industry, academia, and the government for practical discussions of the future of our discipline. Development of new vaccines truly requires a consideration of many things. We examine vaccine development from basic research to marketing. We bring together the people who make the discoveries, make the decisions, fund the work and license the vaccines and foster their interaction with the attendees to share their perspectives of the vaccine industry. The latest information on the new malaria, HIV, tumor, and therapeutic vaccines, DNA vaccines, RNA vaccines, adjuvants, mucosal and other delivery mechanisms will be presented, as will updates on governmental priorities, funding and partnership opportunities.
Organization: GTC
(Courtesy of 12th Vaccines Research & Development: All Things Considered Conference logo, via www.gtcbio.com)
For more information, please visit: www.gtcbio.com/index.php?option=com_conference
July 9, 2014 - July 11, 2014
Hyatt Regency Boston
One Avenue De Lafayette, Boston, MA 02111
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
